{"result": "(\"entity\"<|>ACTH<|>PERSON<|>Adrenocorticotropic hormone (ACTH) is a hormone produced by the pituitary gland that stimulates the adrenal glands to release cortisol, playing a crucial role in the evaluation of adrenal function.)\n##\n(\"entity\"<|>HYPERALDOSTERONISMO PRIMARIO<|>EVENT<|>Primary hyperaldosteronism is a condition characterized by excessive production of aldosterone, often evaluated through the aldosterone/renin ratio in patients with adrenal incidentalomas.)\n##\n(\"entity\"<|>METANEFRINAS<|>PERSON<|>Metanephrines are metabolites of catecholamines that are measured in plasma or urine to assess for pheochromocytoma and other adrenal tumors.)\n##\n(\"entity\"<|>HORMONAS SEXUALES<|>PERSON<|>Sex hormones are hormones that play a role in sexual development and function, which may be evaluated in patients with suspected adrenal tumors.)\n##\n(\"entity\"<|>FARMACOS INHIBIDORES DE LA ENZIMA CONVERTIDORA DE ANGIOTENSINA<|>ORGANIZATION<|>Medications that inhibit the angiotensin-converting enzyme, affecting blood pressure regulation and potentially influencing adrenal function tests.)\n##\n(\"entity\"<|>ANTAGONISTAS DEL RECEPTOR DE ANGIOTENSINA II<|>ORGANIZATION<|>Drugs that block the action of angiotensin II, used in the treatment of hypertension and may impact adrenal function test results.)\n##\n(\"relationship\"<|>ACTH<|>DHEA<|>ACTH stimulates the production of DHEA in the adrenal glands, making it a key hormone in the evaluation of adrenal function.<|>7)\n##\n(\"relationship\"<|>HYPERALDOSTERONISMO PRIMARIO<|>ALDOSTERONA<|>Primary hyperaldosteronism is directly related to excessive aldosterone production, often diagnosed through specific hormonal evaluations.<|>8)\n##\n(\"relationship\"<|>METANEFRINAS<|>INCIDENTALOMA SUPRARRENAL<|>Metanephrines are measured in patients with adrenal incidentalomas to rule out pheochromocytoma and assess adrenal tumor activity.<|>7)\n##\n(\"relationship\"<|>HORMONAS SEXUALES<|>INCIDENTALOMA SUPRARRENAL<|>Sex hormones may be evaluated in patients with adrenal incidentalomas when there is clinical suspicion of adrenal tumors secreting these hormones.<|>6)\n##\n(\"relationship\"<|>FARMACOS INHIBIDORES DE LA ENZIMA CONVERTIDORA DE ANGIOTENSINA<|>RENINA<|>ACE inhibitors can affect renin levels, which is important in the assessment of adrenal function and related disorders.<|>5)\n##\n(\"relationship\"<|>ANTAGONISTAS DEL RECEPTOR DE ANGIOTENSINA II<|>RENINA<|>Angiotensin II receptor antagonists can influence renin activity, impacting the interpretation of adrenal function tests.<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 1,8 µg/dl excluye la presencia de hipercortisolismo. Si la intención es intentar evitar al máximo los falsos positivos, debería escogerse un valor de corte de 5 µg/dl. Algunas guías clasifican a los sujetos con valores entre 1,8 y 5 µg/dl como frenación intermedia.\n\nLa DHEA es un andrógeno suprarrenal que se produce bajo el estímulo de la ACTH y, por este motivo, su determinación puede ser útil en el estudio funcional de secreción autónoma de cortisol en el incidentaloma suprarrenal. Un nivel de DHEA-S suprimido sugiere una se-\n---\n# SUPRARRENALES\n\ncreción suprimida crónicamente de ACTH y, por lo tanto, puede ser sugerente de secreción autónoma de cortisol por la lesión evaluada.\n\nEl ratio de aldosterona/actividad de renina plasmática debe realizarse a primera hora de la mañana, con el paciente sentado. No precisa la retirada de la medicación antihipertensiva, con algunas salvedades. Los antagonistas de la aldosterona (espironolactona y eplerenona) deben ser retirados 6 semanas antes para poder hacer una interpretación correcta, excepto cuando persiste la hipopotasemia a pesar del tratamiento, lo que indica que el receptor de aldosterona está completamente bloqueado y la actividad de renina plasmática sí que podría suprimirse en el paciente con hiperaldosteronismo primario, siendo esta la única en la que el ratio ALD/ARP sería útil. Otros diuréticos ahorradores de potasio, amilorida o triamtereno no interfieren, a menos que se utilicen en dosis elevadas. Los fármacos inhibidores de la enzima convertidora de angiotensina (IECA) y los antagonistas del receptor de angiotensina II (ARA-II) aumentan el valor de la ARP y disminuyen el ratio, dando lugar a posibles falsos negativos, por lo que no sería interpretable un resultado normal. Sin embargo, una actividad de renina plasmática suprimida en un paciente en tratamiento con IECA/ARA-II es muy sugerente de hiperaldosteronismo primario.\n\nReferencias:\n- Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.\n- Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice. Guideline in collaboration with the European Network for the Study of adrenal tumors. Eur J Endocrinol. 2016;175:G1-G34.\n- Recasens Sala M. Incidentaloma adrenal. Manual de Endocrinología y Nutrición. Disponible en: https://manual.seen.es (última modificación: 25 de noviembre de 2015).\n- Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.\n- Young WF, Jr, Kebebew E. The adrenal incidentaloma. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com. Literature review current through: Apr. 2019.\n\nLa supresión con dexametasona, la concentración de metanefrinas fraccionadas en plasma o en orina de 24 horas y, en pacientes hipertensos o con hipopotasemia no explicada, la determinación del cociente ALD/ARP serían las pruebas básicas en el estudio funcional del incidentaloma suprarrenal.\n\nLa supresión con dexametasona es la prueba de elección para valorar la posibilidad de secreción autónoma de cortisol. Si la intención es detectar el máximo de pacientes a expensas de falsos positivos, se debería escoger el punto de corte de 1,8 µg/dl. De esta manera, podríamos asumir que un valor de cortisol inferior a 1,8 µg/dl excluye la presencia de hipercortisolismo. Si la intención es intentar evitar al máximo los falsos positivos, debería escogerse un valor de corte de 5 µg/dl. Algunas guías clasifican a los sujetos con valores entre 1,8 y 5 µg/dl como frenación intermedia.\n\nLa solicitud de DHEA-S en el estudio del incidentaloma suprarrenal es controvertida. Algunos estudios sugieren que puede ser un marcador, aunque con más especificidad que sensibilidad, de malignidad. El resto de hormonas sexuales deberían solicitarse en caso de clínica sugestiva o ante la sospecha de carcinoma suprarrenal, ya que es muy rara la secreción de hormonas sexuales por un\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>A medical textbook edited by Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, and Loscazo J, providing comprehensive information on internal medicine, including adrenal disorders.)\n##\n(\"entity\"<|>EUROPEAN SOCIETY OF ENDOCRINOLOGY<|>ORGANIZATION<|>A professional organization that provides clinical practice guidelines for the management of adrenal incidentalomas and other endocrine disorders.)\n##\n(\"entity\"<|>UPTODATE<|>ORGANIZATION<|>An online clinical resource that provides evidence-based information on various medical topics, including adrenal incidentalomas.)\n##\n(\"entity\"<|>DHEA<|>PERSON<|>Dehydroepiandrosterone (DHEA) is an adrenal androgen produced under the stimulation of ACTH, useful in studying cortisol secretion in adrenal incidentalomas.)\n##\n(\"entity\"<|>DEXAMETASONA<|>EVENT<|>Dexamethasone suppression test is a diagnostic procedure used to evaluate the possibility of autonomous cortisol secretion in patients with adrenal incidentalomas.)\n##\n(\"entity\"<|>ALDOSTERONA<|>PERSON<|>A hormone produced by the adrenal glands that helps regulate blood pressure and fluid balance, often measured in relation to adrenal disorders.)\n##\n(\"entity\"<|>RENINA<|>PERSON<|>Renin is an enzyme secreted by the kidneys that plays a key role in blood pressure regulation and is often measured in conjunction with aldosterone in adrenal studies.)\n##\n(\"entity\"<|>INCIDENTALOMA SUPRARRENAL<|>EVENT<|>An adrenal incidentaloma is an adrenal mass discovered incidentally during imaging studies performed for other reasons, which may require further evaluation for hormonal activity.)\n##\n(\"relationship\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>EUROPEAN SOCIETY OF ENDOCRINOLOGY<|>The European Society of Endocrinology provides clinical guidelines referenced in the Harrison textbook for managing adrenal disorders.<|>5)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY OF ENDOCRINOLOGY<|>UPTODATE<|>Both organizations provide resources and guidelines for the management of adrenal incidentalomas and related conditions.<|>5)\n##\n(\"relationship\"<|>DHEA<|>INCIDENTALOMA SUPRARRENAL<|>DHEA levels are evaluated in the context of adrenal incidentalomas to assess hormonal activity and potential malignancy.<|>7)\n##\n(\"relationship\"<|>DEXAMETASONA<|>INCIDENTALOMA SUPRARRENAL<|>The dexamethasone suppression test is a key diagnostic procedure used to evaluate adrenal incidentalomas for autonomous cortisol secretion.<|>8)\n##\n(\"relationship\"<|>ALDOSTERONA<|>RENINA<|>The aldosterone/renin ratio is a critical measurement in diagnosing conditions related to adrenal function, particularly in cases of primary hyperaldosteronism.<|>6)\n##\n(\"relationship\"<|>INCIDENTALOMA SUPRARRENAL<|>DHEA<|>DHEA levels are assessed in patients with adrenal incidentalomas to determine the functional status of the adrenal mass.<|>6)\n<|COMPLETE|>"}]}